Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis

English version České info

Background:
Women may have persistent risk of HIV acquisition during pregnancy and postpartum. Estimating risk of HIV during these periods is important to inform optimal prevention approaches. We performed a systematic review and meta-analysis to estimate maternal HIV incidence during pregnancy/postpartum and to compare mother-to-child HIV transmission (MTCT) risk among women with incident versus chronic infection.

Methods and Findings:
We searched PubMed, Embase, and AIDS-related conference abstracts between January 1, 1980, and October 31, 2013, for articles and abstracts describing HIV acquisition during pregnancy/postpartum. The inclusion criterion was studies with data on recent HIV during pregnancy/postpartum. Random effects models were constructed to pool HIV incidence rates, cumulative HIV incidence, hazard ratios (HRs), or odds ratios (ORs) summarizing the association between pregnancy/postpartum status and HIV incidence, and MTCT risk and rates. Overall, 1,176 studies met the search criteria, of which 78 met the inclusion criterion, and 47 contributed data. Using data from 19 cohorts representing 22,803 total person-years, the pooled HIV incidence rate during pregnancy/postpartum was 3.8/100 person-years (95% CI 3.0–4.6): 4.7/100 person-years during pregnancy and 2.9/100 person-years postpartum (p = 0.18). Pooled cumulative HIV incidence was significantly higher in African than non-African countries (3.6% versus 0.3%, respectively; p<0.001). Risk of HIV was not significantly higher among pregnant (HR 1.3, 95% CI 0.5–2.1) or postpartum women (HR 1.1, 95% CI 0.6–1.6) than among non-pregnant/non-postpartum women in five studies with available data. In African cohorts, MTCT risk was significantly higher among women with incident versus chronic HIV infection in the postpartum period (OR 2.9, 95% CI 2.2–3.9) or in pregnancy/postpartum periods combined (OR 2.3, 95% CI 1.2–4.4). However, the small number of studies limited power to detect associations and sources of heterogeneity.

Conclusions:
Pregnancy and the postpartum period are times of persistent HIV risk, at rates similar to “high risk” cohorts. MTCT risk was elevated among women with incident infections. Detection and prevention of incident HIV in pregnancy/postpartum should be prioritized, and is critical to decrease MTCT.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Incident HIV during Pregnancy and Postpartum and Risk of Mother-to-Child HIV Transmission: A Systematic Review and Meta-Analysis. PLoS Med 11(2): e32767. doi:10.1371/journal.pmed.1001608
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001608

Souhrn

Zdroje

1. Perinatal HIV prevention aims for elimination. AIDS Read 12: 146, 150.

2. BransonBM, HandsfieldHH, LampeMA, JanssenRS, TaylorAW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55: 1–17.

3. MoodleyD, EsterhuizenTM, PatherT, ChettyV, NgalekaL (2009) High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 23: 1255–1259.

4. Tabu F, Ngonzi J, Mugyenyi G, Bajunirwe F, Mayanja R, et al. (2013) Prevalence of HIV infection among parturients with a negative primary test during the antenatal period at Mbarara Regional Referral Hospital, Uganda [abstract]. SpROGs 2013 Conference; 5–6 Dec 2013; Nottingham, United Kingdom.

5. MoodleyD, EsterhuizenT, ReddyL, MoodleyP, SinghB, et al. (2011) Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis 203: 1231–1234.

6. GrayRH, LiX, KigoziG, SerwaddaD, BrahmbhattH, et al. (2005) Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 366: 1182–1188.

7. DunnDT, NewellML, AdesAE, PeckhamCS (1992) Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340: 585–588.

8. World Health Organization (2012) Global monitoring framework and strategy for the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva: World Health Organization.

9. GreenlandS (1994) Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 140: 290–296.

10. ThompsonSG, HigginsJP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559–1573.

11. Wells G, Shea B, O'Connell D, Peterson J, Welch V, et al. (1999) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa: Ottawa Hospital Research Institute.

12. KimAA, McDougalJS, HargroveJ, RehleT, Pillay-Van WykV, et al. (2010) Evaluating the BED capture enzyme immunoassay to estimate HIV incidence among adults in three countries in sub-Saharan Africa. AIDS Res Hum Retroviruses 26: 1051–1061.

13. RehleT, ShisanaO, PillayV, ZumaK, PurenA, et al. (2007) National HIV incidence measures—new insights into the South African epidemic. S Afr Med J 97: 194–199.

14. HargroveJW, HumphreyJH, MutasaK, ParekhBS, McDougalJS, et al. (2008) Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22: 511–518.

15. LiangK, GuiX, ZhangYZ, ZhuangK, MeyersK, et al. (2009) A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding. J Infect Dis 200: 682–686.

16. Lu L, Motswere-Chirwa C, Kegwaila K, Matambo S, Kolobe T, et al. (2011) HIV incidence in women during the first postpartum year and implications for prevention of mother-to-child transmission (PMTCT) programs—Francistown, Botswana, 2010 [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 Jul 2011; Rome, Italy.

17. PalasanthiranP, ZieglerJB, StewartGJ, StuckeyM, ArmstrongJA, et al. (1993) Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant. J Infect Dis 167: 441–444.

18. Singh A, Lampe MA, Surendera Babu A, Rao S, Borkowf CB, et al. (2012) HIV seroconversion during prgnancy and mother-to-child HIV transmission: data from the Enhanced Perinatal Surveillance Project, United States, 2005–2010 [abstract]. 19th International AIDS Conference; 22–27 Jul 2012; Washington, District of Columbia, US.

19. ColebundersR, KapitaB, NekweiW, BahweY, LebugheI, et al. (1988) Breastfeeding and transmission of HIV. Lancet 2: 1487.

20. HiraSK, MangrolaUG, MwaleC, ChintuC, TemboG, et al. (1990) Apparent vertical transmission of human immunodeficiency virus type 1 by breast-feeding in Zambia. J Pediatr 117: 421–424.

21. HumphreyJH, MarindaE, MutasaK, MoultonLH, IliffPJ, et al. (2010) Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ 341: c6580.

22. Van de PerreP, SimononA, MsellatiP, HitimanaDG, VairaD, et al. (1991) Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med 325: 593–598.

23. TovoPA, PalombaE, GabianoC, GalliL, de MartinoM (1991) Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynaecol 98: 940–942.

24. RoongpisuthipongA, SiriwasinW, SimondsRJ, SangtaweesinV, VanpraparN, et al. (2001) HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr 26: 348–351.

25. BirkheadGS, PulverWP, WarrenBL, HackelS, RodriguezD, et al. (2010) Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002–2006. Obstet Gynecol 115: 1247–1255.

26. NesheimS, JamiesonDJ, DannerSP, MaupinR, O'SullivanMJ, et al. (2007) Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. Am J Obstet Gynecol 197: 149.e141–5.

27. Joint United Nations Programme on HIV/AIDS (2012) UNAIDS World AIDS Day Report 2012. Geneva: Joint United Nations Programme on HIV/AIDS.

28. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, et al. (2013) Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003) [abstract]. 20th Conference on Retroviruses and Opportunistic Infections 3–6 Mar 2013; Atlanta, Georgia, US.

29. Abdool KarimQ, Abdool KarimSS, FrohlichJA, GroblerAC, BaxterC, et al. (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168–1174.

30. PriceMA, RidaW, MwangomeM, MutuaG, MiddelkoopK, et al. (2012) Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J Acquir Immune Defic Syndr 59: 185–193.

31. KaulR, KimaniJ, NagelkerkeNJ, FonckK, NgugiEN, et al. (2004) Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 291: 2555–2562.

32. CelumC, WaldA, HughesJ, SanchezJ, ReidS, et al. (2008) Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371: 2109–2119.

33. CelumC, WaldA, LingappaJR, MagaretAS, WangRS, et al. (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 427–439.

34. Watson-JonesD, WaldA, CelumC, LingappaJ, WeissHA, et al. (2010) Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol 48: 3496–3503.

35. BaetenJM, DonnellD, NdaseP, MugoNR, CampbellJD, et al. (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367: 399–410.

36. BaetenJM, RichardsonBA, MartinHLJr, NyangePM, LavreysL, et al. (2000) Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. J Acquir Immune Defic Syndr 24: 458–464.

37. FowkeKR, NagelkerkeNJ, KimaniJ, SimonsenJN, AnzalaAO, et al. (1996) Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348: 1347–1351.

38. MugoNR, HeffronR, DonnellD, WaldA, WereEO, et al. (2011) Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS 25: 1887–1895.

39. WandH, RamjeeG (2011) Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: implications for prevention policy and planning. AIDS Behav 15: 479–486.

40. HeffronR, DonnellD, ReesH, CelumC, MugoN, et al. (2012) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 12: 19–26.

41. MorrisonCS, ChenPL, KwokC, RichardsonBA, ChipatoT, et al. (2010) Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 24: 1778–1781.

42. MorrisonCS, WangJ, Van Der PolB, PadianN, SalataRA, et al. (2007) Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS 21: 1027–1034.

43. KeatingMA, HamelaG, MillerWC, MosesA, HoffmanIF, et al. (2012) High HIV incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: implications for the risk of HIV acquisition. PLoS ONE 7: e39109.

44. ClelandJG, AliMM, Capo-ChichiV (1999) Post-partum sexual abstinence in West Africa: implications for AIDS-control and family planning programmes. AIDS 13: 125–131.

45. TahaTE, HooverDR, DallabettaGA, KumwendaNI, MtimavalyeLA, et al. (1998) Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12: 1699–1706.

46. HumphreyJH, HargroveJW, MalabaLC, IliffPJ, MoultonLH, et al. (2006) HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS 20: 1437–1446.

47. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach. Geneva: World Health Organization.

48. JohnsonLF, StinsonK, NewellML, BlandRM, MoultrieH, et al. (2012) The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 59: 417–425.

49. BlackV, OsihR, ReesHV, ChersichMF (2009) High HIV incidence or poor test performance? AIDS 23: 2234–2235.

50. LaeyendeckerO, ChurchJD, OliverAE, MwathaA, OwenSM, et al. (2010) Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS ONE 5: e13259.

51. World Health Organization (2011) When and how to use assays for recent infection to estimate HIV incidence at a population level. Geneva: World Health Organization.

52. DimitrovD, BoilyMC, MarrazzoJ, BeigiR, BrownER (2013) Population-level benefits from providing effective HIV prevention means to pregnant women in high prevalence settings. PLoS ONE 8: e73770.

53. BernasconiD, TavoschiL, RegineV, RaimondoM, GamaD, et al. (2010) Identification of recent HIV infections and of factors associated with virus acquisition among pregnant women in 2004 and 2006 in Swaziland. J Clin Virol 48: 180–183.

54. Boly L, Ndile J, Zwartz F, Sabwa H, Musyoka K, et al. (2011) Screening for HIV seroconversion among pregnant women in rural Namibia [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 Jul 2011; Rome, Italy.

55. KharsanyAB, HancockN, FrohlichJA, HumphriesHR, Abdool KarimSS, et al. (2010) Screening for ‘window-period’ acute HIV infection among pregnant women in rural South Africa. HIV Med 11: 661–665.

56. KiefferMP, NhlabatsiB, MahdiM, HoffmanHJ, KudiaborK, et al. (2011) Improved detection of incident HIV infection and uptake of PMTCT services in labor and delivery in a high HIV prevalence setting. J Acquir Immune Defic Syndr 57: e85–e91.

57. MbizvoMT, KasuleJ, MahomedK, NathooK (2001) HIV-1 seroconversion incidence following pregnancy and delivery among women seronegative at recruitment in Harare, Zimbabwe. Cent Afr J Med 47: 115–118.

58. MunjomaMW, MhlangaFG, MapingureMP, KurewaEN, MashavaveGV, et al. (2010) The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in Zimbabwe. BMC Public Health 10: 668.

59. ReidSE, DaiJY, WangJ, SichalweBN, AkpomiemieG, et al. (2010) Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 53: 606–613.

60. RollinsNC, DedicoatM, DanaviahS, PageT, BishopK, et al. (2002) Prevalence, incidence, and mother-to-child transmission of HIV-1 in rural South Africa. Lancet 360: 389.

61. De Schacht C, Ismael N, Santos I, Calu N, Vubil A, et al. (2011) HIV incidence during pregnancy and post-partum period in Southern Mozambique: impact on vertical HIV transmission [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 Jul 2011; Rome, Italy.

62. GayCL, MwapasaV, MurdochDM, KwiekJJ, FiscusSA, et al. (2010) Acute HIV infection among pregnant women in Malawi. Diagn Microbiol Infect Dis 66: 356–360.

63. BraunsteinSL, IngabireCM, KestelynE, UwizeraAU, MwamarangweL, et al. (2011) High human immunodeficiency virus incidence in a cohort of Rwandan female sex workers. Sex Transm Dis 38: 385–394.

64. KinuthiaJ, KiarieJN, FarquharC, RichardsonB, NduatiR, et al. (2010) Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res 8: 510–514.

65. LeroyV, Van de PerreP, LepageP, SabaJ, NsengumuremyiF, et al. (1994) Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988–1992. AIDS 8: 983–986.

66. WawerMJ, SewankamboNK, SerwaddaD, QuinnTC, PaxtonLA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353: 525–535.

67. WoldayD, MelesH, HailuE, MesseleT, MengistuY, et al. (2007) Temporal trends in the incidence of HIV infection in antenatal clinic attendees in Addis Ababa, Ethiopia, 1995–2003. J Intern Med 261: 132–137.

68. Imade G, Sagay S, Musa J, Ocheke A, Adeniyl D, et al. (2012) Declining rates of maternal HIV infection detected at delivery settings in north central Nigeria [abstract]. 19th International AIDS Conference; 22–27 Jul 2012; Washington, District of Columbia, US.

69. Traore CAH, Dielbeogo R, Bagre I, Konate D, Meda N, et al. (2012) Evaluation of HIV incidence during pregnancy in Ouagadougou, Burkina Faso [abstract]. 19th International AIDS Conference; 22–27 Jul 2012; Washington, District of Columbia, US.

70. DuanS, ShenS, BulterysM, JiaY, YangY, et al. (2010) Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking route. BMC Public Health 10: 180.

71. SaphonnV, ParekhBS, DobbsT, MeanC, BunLH, et al. (2005) Trends of HIV-1 seroincidence among HIV-1 sentinel surveillance groups in Cambodia, 1999–2002. J Acquir Immune Defic Syndr 39: 587–592.

72. NesheimS, ParekhB, SullivanK, BulterysM, DobbsT, et al. (2005) Temporal trends in HIV Type 1 incidence among inner-city childbearing women in Atlanta: use of the IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 21: 537–544.

73. de Freitas OliveiraCA, UedaM, YamashiroR, RodriguesR, SheppardHW, et al. (2005) Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002. J Clin Microbiol 43: 1439–1442.

74. PandoMA, Gomez-CarrilloM, VignolesM, RubioAE, dos Ramos FariasMS, et al. (2011) Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: a Global Fund Project. AIDS Res Hum Retroviruses 27: 17–23.